Symptoms and Endoscopic Results in Consideration of Pretreatment
Under daily routine conditions and without any intervention by the sponsor regarding the selection of subjects, diagnostic procedures, therapeutic decisions (medicinal and non- medicinal therapy, dose, duration, etc.), routine assessments, the participating physicians (i.e. gastroenterologists) are asked to document relevant data in patients with gastrointestinal disorders.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Symptoms and Endoscopic Results in Consideration of Pretreatment|
- to gain insight into the relationship between subjective gastrointestinal symptoms and findings of a laryngopharyngeal-esophagogastric endoscopy with respect to the medicinal pre-therapy;
- to gain insight into the currently used treatment strategies with esomeprazole depending on endoscopic findings.
|Study Start Date:||September 2005|
|Primary Completion Date:||December 2005 (Final data collection date for primary outcome measure)|
patients with gastrointestinal disorders who need an endoscopy.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00612404
|Study Chair:||Kai Richter, MD||Medical Department AstraZeneca Germany|